- Home
- DBX vs TECH Comparison
DBX vs TECH Comparison
Compare DBX & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBX
- TECH
- Stock Information
- Founded
- DBX 2007
- TECH 1976
- Country
- DBX United States
- TECH United States
- Employees
- DBX N/A
- TECH N/A
- Industry
- DBX Computer Software: Prepackaged Software
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DBX Technology
- TECH Health Care
- Exchange
- DBX Nasdaq
- TECH Nasdaq
- Market Cap
- DBX 8.2B
- TECH 7.8B
- IPO Year
- DBX 2018
- TECH 1989
- Fundamental
- Price
- DBX $28.74
- TECH $47.32
- Analyst Decision
- DBX Buy
- TECH Buy
- Analyst Count
- DBX 4
- TECH 10
- Target Price
- DBX $31.00
- TECH $73.44
- AVG Volume (30 Days)
- DBX 3.6M
- TECH 2.2M
- Earning Date
- DBX 05-08-2025
- TECH 05-07-2025
- Dividend Yield
- DBX N/A
- TECH 0.68%
- EPS Growth
- DBX 1.18
- TECH N/A
- EPS
- DBX 1.48
- TECH 0.83
- Revenue
- DBX $2,541,600,000.00
- TECH $1,208,770,000.00
- Revenue This Year
- DBX N/A
- TECH $7.16
- Revenue Next Year
- DBX $0.04
- TECH $6.36
- P/E Ratio
- DBX $19.42
- TECH $57.01
- Revenue Growth
- DBX 0.79
- TECH 4.72
- 52 Week Low
- DBX $20.68
- TECH $46.01
- 52 Week High
- DBX $33.33
- TECH $83.96
- Technical
- Relative Strength Index (RSI)
- DBX 52.44
- TECH 41.23
- Support Level
- DBX $28.44
- TECH $46.35
- Resistance Level
- DBX $29.06
- TECH $49.92
- Average True Range (ATR)
- DBX 0.63
- TECH 2.24
- MACD
- DBX -0.14
- TECH 0.02
- Stochastic Oscillator
- DBX 20.57
- TECH 15.21
About DBX Dropbox Inc.
Dropbox provides cloud storage and content collaboration tools, focusing on individuals and small to midsize businesses. Founded in 2007, Dropbox was a pioneer in the file sync and share market. In recent years, the firm has been emphasizing its Dash product, which facilitates AI-powered universal search across unstructured cloud data.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.